by Megan Burbank
On Wednesday, Aug. 16, the Fifth Circuit Court of Appeals ruled that the Food and Drug Administration should revoke its approval for mifepristone, one of two drugs commonly used in medication abortions. The case has drawn widespread attention, given the impact it could have on access to mifepristone and spurred confusion about whether medication abortion is still available.
It is. Before we get into the nitty-gritty, it’s important to be clear on this point: Mifepristone remains legal and accessible in states where abortion is, and will remain that way until the case makes its way to the Supreme Court. If you take away just one piece of information from this column, that should be it. But if you want to know more, let’s dig in.
Continue reading OPINION | What The Latest Mifepristone Ruling Really Means